Longeveron Reports ELPIS II Results for Laromestrocel
MIAMI — September 16, 2026 Longeveron Inc. announced topline results from its Phase 2b ELPIS II clinical trial evaluating...
MSC Therapy
Advertisement
INmune Bio Reaches Commercial CORDStrom Manufacturing Milestone
BOCA RATON, Fla. | July 20, 2026 INmune Bio Inc. announced the successful completion of a major commercial manufacturing...
Caris Life Sciences Unveils AI Test for Breast Cancer Recurrence
IRVING, Texas, May 5, 2026 Caris Life Sciences has announced the launch of Caris MI Clarity™, an advanced AI-powered...
Gallant Advances Stem Cell Therapy for Canine OA
SAN DIEGO, May 6, 2026 Gallant, an emerging animal health biotechnology company focused on regenerative veterinary medicine, has announced...
Advertisement
